William W. Yang

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Journal: Cancer research

Published: August 06, 2025

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Journal: Cancer research

Published: August 06, 2025

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells.

Journal: iScience

Published: June 13, 2025

PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.

Journal: Oncogene

Published: June 17, 2024

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.

Journal: Cancer cell

Published: March 17, 2021

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor.

Journal: Molecular cancer therapeutics

Published: April 09, 2020

Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.

Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42.

Journal: Carcinogenesis

Published: June 24, 2019

Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

Journal: Molecular cancer

Published: June 05, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026